Analyst Price Targets — ASIX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 12, 2026 1:47 pm | David Silver | Loop Capital Markets | $25.00 | $19.80 | StreetInsider | AdvanSix (ASIX) PT Raised to $25 at Freedom Capital Markets |
| January 15, 2026 11:09 am | — | Truist Financial | $19.00 | $18.44 | TheFly | AdvanSix initiated with a Hold at Truist |
| May 19, 2025 7:47 am | Charles Neivert | Piper Sandler | $32.00 | $23.48 | StreetInsider | Piper Sandler Upgrades AdvanSix (ASIX) to Overweight |
| March 18, 2025 10:45 am | — | UBS | $35.00 | $23.30 | TheFly | AdvanSix price target lowered to $35 from $39 at Piper Sandler |
| November 8, 2024 1:47 pm | Charles Neivert | Piper Sandler | $39.00 | $31.02 | StreetInsider | AdvanSix (ASIX) PT Raised to $39 at Piper Sandler |
| April 9, 2024 10:01 am | Vincent Anderson | Stifel Nicolaus | $43.00 | $28.99 | StreetInsider | AdvanSix (ASIX) PT Raised to $43 at Stifel |
Latest News for ASIX
AdvanSix (ASIX) faces significant short-term headwinds, with a 90% net income drop and negative FCF in 2Q26, driving a >20% share price decline. ASIX's structurally advantageous single-feedstock model is outweighed by weak end-market demand, limited pricing power, and high exposure to cyclical sectors like fertilizers and nylon. I lower my price target to $16/share, reflecting prolonged macro weakness and industry…
AdvanSix Inc. (ASIX) Q2 2026 Earnings Call Transcript
AdvanSix NYSE: ASIX reported second-quarter 2026 sales of $421 million, up approximately 3% from a year earlier, as higher pricing offset lower volumes across its portfolio. Adjusted EBITDA was $32 million, down $24 million year over year, while adjusted earnings per share declined $1.05 to $0.19.
AdvanSix (NYSE: ASIX), a vertically integrated chemistry company serving diverse end markets, today announced its financial results for the second quarter endin
PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Second Quarter 2026 Financial Results.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for ASIX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.